Reply to thread

I've just come across this company. They seem to have quite a few programs going for such a small oncology drug developer and it seems they are all fairly early stage - some in animal model testing and at least one phase 1 human trial for one of their treatments. I note the company is currently conducting a share purchase plan. I'm doing some reading on them. The bloke running the show is a biotech entrepreneur/banker.